Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fedor Simko

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|July 23, 2016
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular PathophysiologyJaroslav Hrenak, Ludovit Paulis, Fedor Simko
Expert Opinion on Investigational Drugs|August 25, 2012
Cardiovascular effects of melatonin receptor agonistsLudovit Paulis, Fedor Simko, Moshe Laudon
International Journal of Molecular Sciences|May 5, 2021
The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac RemodellingMichaela Adamcova, Ippei Kawano, Fedor Simko
Revista Espanola De Cardiologia (English Ed.)|September 29, 2022
Correction in article by Baka et al. "Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessment", Rev Esp Cardiol. 2022;75:355-356Tomas Baka, Alberto Domínguez-Rodríguez, Fedor Simko
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 14, 2019
Melatonin as a rational alternative in the conservative treatment of resistant hypertensionFedor Simko, Russel J Reiter, Ludovit Paulis
Revista Espanola De Cardiologia (English Ed.)|December 21, 2021
Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessmentTomas Baka, Alberto Domínguez-Rodríguez, Fedor Simko
Eclinicalmedicine|August 22, 2024
Considering chronotype to improve hypertension managementTomas Baka, Darlynn M Rojo-Wissar, Fedor Simko
Medicinal Research Reviews|January 7, 2022
Cardiovascular therapeutics: A new potential for anxiety treatment?Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.
Current Pharmaceutical Design|March 29, 2022
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A PerspectiveTomas Baka, Kristina Repova, Ivan Luptak, et al.
International Journal of Molecular Sciences|April 3, 2021
Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 InteractionsFedor Simko, Jaroslav Hrenak, Michaela Adamcova, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|July 23, 2016
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular PathophysiologyJaroslav Hrenak, Ludovit Paulis, Fedor Simko
Expert Opinion on Investigational Drugs|August 25, 2012
Cardiovascular effects of melatonin receptor agonistsLudovit Paulis, Fedor Simko, Moshe Laudon
International Journal of Molecular Sciences|May 5, 2021
The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac RemodellingMichaela Adamcova, Ippei Kawano, Fedor Simko
Revista Espanola De Cardiologia (English Ed.)|September 29, 2022
Correction in article by Baka et al. "Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessment", Rev Esp Cardiol. 2022;75:355-356Tomas Baka, Alberto Domínguez-Rodríguez, Fedor Simko
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 14, 2019
Melatonin as a rational alternative in the conservative treatment of resistant hypertensionFedor Simko, Russel J Reiter, Ludovit Paulis
Revista Espanola De Cardiologia (English Ed.)|December 21, 2021
Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessmentTomas Baka, Alberto Domínguez-Rodríguez, Fedor Simko
Eclinicalmedicine|August 22, 2024
Considering chronotype to improve hypertension managementTomas Baka, Darlynn M Rojo-Wissar, Fedor Simko
Medicinal Research Reviews|January 7, 2022
Cardiovascular therapeutics: A new potential for anxiety treatment?Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.
Current Pharmaceutical Design|March 29, 2022
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A PerspectiveTomas Baka, Kristina Repova, Ivan Luptak, et al.
International Journal of Molecular Sciences|April 3, 2021
Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 InteractionsFedor Simko, Jaroslav Hrenak, Michaela Adamcova, et al.
Pageof 9